Meanwhile, leading firms in China, such as Jiangsu Hengrui Pharmaceuticals, and in Europe, notably Sandoz, have also announced plans to market generic semaglutide
For instance, a clinical trial involving more than 1,900 adults with obesity found that those who took oral Semaglutide GLP-1 for 68 weeks lost an average of 12.4% of their body weight
Weight Management & Biological Benefits
This framing is uncomfortable for many people who view medication as something you take temporarily until a problem resolves, but it aligns with the biological reality of obesity as a chronic disease with chronic neurohormonal underpinnings
Side Effects of Semaglutide and Tirzepatide Both medications can cause side effects, especially during the early stages of treatment or after dose increases